Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
Elisabeth S GruberGerd JomrichDietmar TamandlMichael GnantMartin SchindlKlaus SahoraPublished in: PloS one (2019)
Patients with sarcopenia and sarcopenic obesity undergoing resection for PDAC have a significantly shorter overall survival and a higher complication rate. The assessment of body composition in these patients may provide a broader understanding of patients' individual condition and guide specific supportive strategies in patients at risk.
Keyphrases
- prognostic factors
- end stage renal disease
- body composition
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- metabolic syndrome
- insulin resistance
- squamous cell carcinoma
- emergency department
- weight loss
- adipose tissue
- patient reported outcomes
- physical activity
- resistance training
- weight gain
- bone mineral density